Table 2.

Regression Analyses and Analog to ANOVA Examining Moderators of Treatment Effects in BT and SRI Trials

	BT Trials (n = 7)				SRI Trials (n = 6)
Study Characteristics	B	SE	z	p	B	SE	z	p
Average participant age	−0.001	0.04	−0.02	0.98	0.02	0.06	0.26	0.79
Percentage of comorbid anxiety disorders	−0.03	0.03	−0.97	0.33	−0.01	0.01	−0.87	0.39
Percentage of comorbid depressive disorders	−0.02	0.03	−0.51	0.61	−0.02	0.02	−0.84	0.40
Average number of therapeutic contact hours	0.17	0.07	2.58	0.01	NA	NA	NA	NA
Study methodological quality rating	−0.004	0.06	−0.08	0.94	0.01	0.03	0.09	0.92
		Q	(df)	p		Q	(df)	p
Youth, Adult, or Mixed Participants		2.03	2	0.36		1.13	1	0.29
Clinician versus self-report ratings		2.93	1	0.09		0.03	1	0.87
Therapy subtype comparisons		10.01	1	0.002		1.09	1	0.30
Control Condition Comparison		2.09	2	0.35		0.90	1	0.34

Note: BT = Behavior Therapy, SRI = Serotonin Reuptake Inhibitors, NA = not applicable